Today, The Panic-Proof Portfolio (Stockchase Research) and Paul Harris, CFA commented about whether ESLOY, MSFT, META, TRI.TO, CLS.TO, MBGYY, ZTS, MSCI, NVDA, BAC, PLTR, ATZ.TO, ACN, SHOP.TO, CSU.TO, AC.TO, EQB.TO, HLPR.TO, VDY.TO, VGG.TO are stocks to buy or sell.
Earnings have been strong coming into 2026, being estimates, and GDP is higher than in Q4 2025. The US consumer has been robust. The one glitch is rising inflation because of the US-Iran war, raising inflation and rates. The Fed is hinting at a rate increase later this year, but should return to better inflation numbers later. The Fed is worried about inflation, still targeting 2%, which hasn't been at that level for 5 years. Nothing wrong with the Fed adding liquidity to the system in 2020, but they never pulled back from it; they should liquify only to save the economy, then stop it.
Are different: CSU buys companies vs. Shopify which is a pure tech company. What PE do you want to pay for CSU? 25x? 20x? SHOP is great and continues to grow. The market perception of AI hurting these companies is wrong. Both are worth buying. He prefers CSU but buy it at a lower PE.
Are different: CSU buys companies vs. Shopify which is a pure tech company. What PE do you want to pay for CSU? 25x? 20x? SHOP is great and continues to grow. The market perception of AI hurting these companies is wrong. Both are worth buying. He prefers CSU but buy it at a lower PE.
Like many consulting companies, ACN has had a rough time because the market thinks AI will wipe them out. AI will effect their business, but ACN will use AI to be more effective. They could perform the same amount of work with fewer people, but ACN is still needed to help bigger corporations. ACN and similar businesses may be stuck--lay off employees or not? These companies continue to do well--their top lines are still growing.
Painful. Last quarter's numbers were not as bad as expected, and they continue to grow. Their pet business since Covid has flattened. They have potential blockbuster pet drugs coming out in the next 6-12 months. He likes the business for being in an oligopoly, and people spend money on their pets. The market expected ZTS to grow too quickly. Would buy it here rather than sell it.
We reiterate VGG as a TOP PICK. A low-MER ETF that focuses on US dividend growing stocks. It has performed well in good times and bad. We recommend trailing up the stop (from $99) to $108, looking to achieve $132 -- upside potential of 16%. Yield 1.0%